Last reviewed · How we verify

NCT06138574: Effects of Dex

Effects of Dexmetomidine and Remifentanil Used for Controlled Hypotension in Septorhinoplasty Surgery on Cardiac Electrophysiology: Prospective Randomized Study

Status unknown NA Last updated 18 November 2023
What this trial tests

NA trial testing Dexmedetomidine in Rhinoplasty Surgery in 72 participants. Status unknown.

Timeline
1 December 2023
Primary endpoint
1 February 2024
30 March 2024

Quick facts

Lead sponsorSaglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment72
Start date1 December 2023
Primary completion1 February 2024
Estimated completion30 March 2024

Drugs / interventions tested

Conditions studied

Sponsor

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

Who can join

Adults 17 to 45, any sex, with Rhinoplasty Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our aim in this treatment was to reveal the effects of remifentanil and dexmetomidine, which we used to provide controlled hypotension in septorhinoplasty surgery, on cardiac electrophysiology. We planned to compare the patients by recording preoperative and postoperative ECGs. We also planned to record the patients' intraoperative blood pressure, saturation, and pulse rate, rickeragitation scale, and vas score.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dexmedetomidine

Trials testing the same drug.

Other Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06138574.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing